Manufacturer of Controlled Substances; Notice of Application, 15219 [E6-4351]

Download as PDF Federal Register / Vol. 71, No. 58 / Monday, March 27, 2006 / Notices 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301 et seq. (‘‘the Act’’), Open SystemC Initiative (‘‘OSCI’’) has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act’s provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Bluespec. Inc., Waltham, MA; Canon Inc., Tokyo, Japan; Carbon Design Systems, Waltham, MA; Doulos Ltd., Ringwood, Hampshire, United Kingdom, GreenSocs Ltd., Cambridge, United Kingdom; Jeda Technologies, Inc., Los Altos, CA; and Tenison Technology EDA Ltd., Cambridge, United Kingdom have been added as parties to this venture. Also, NEC Electronics, Inc., Santa Clara, CA; Panasonic, Secaucus, NJ; and Verisity Design, Inc., Mountain View, CA have withdrawn as parties to this venture. No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and OSCI intends to file additional written notification disclosing all changes in membership. On October 9, 2001, OSCI filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on January 3, 2002 (67 FR 350). The last notification was filed with the Department on May 9, 2005. A notice was published in the Federal Register pursuant to section 6(b) of the Act on June 3, 2005 (70 FR 32654). Dorothy B. Fountain, Deputy Director of Operations, Antitrust Division. [FR Doc. 06–2925 Filed 3–24–06; 8:45 am] Administration (DEA) as a bulk manufacturer of the basic classes of controlled substances listed in Schedule I and II: Drug Schedule Marihuana (7360) ......................... Tetrahydrocannabinols (7370) ..... Amphetamine (1100) .................... Methylphenidate (1724) ................ Pentobarbital (2270) ..................... Hydrocodone (9193) ..................... Meperidine(9230) ......................... Dextropropoxyphene (9273) ......... Fentanyl (9801) ............................ I I II II II II II II II The company plans to manufacture bulk controlled substances for use in product development and for distribution to its customers. In reference to drug code 7360 (Marihuana), the company plans to bulk manufacture cannabindiol as a synthetic intermediate. This controlled substance will be further synthesized to bulk manufacture a synthetic THC (7370). No other activity for this drug code is authorized for this registration. Any other such applicant and any person who is presently registered with DEA to manufacture such a substance may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR § 1301.33(a). Any such written comments or objections being sent via regular mail may be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Attention: DEA Federal Register Representative, Liaison and Policy Section (ODL); or any being sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed no later than May 1, 2006. Dated: March 20, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6–4351 Filed 3–24–06; 8:45 am] BILLING CODE 4410–11–M DEPARTMENT OF JUSTICE Drug Enforcement Administration wwhite on PROD1PC65 with NOTICES VerDate Aug<31>2005 18:19 Mar 24, 2006 Jkt 208001 NATIONAL SCIENCE FOUNDATION Advisory Committee for Environmental Research and Education; Notice of Meeting In accordance with the Federal Advisory Committee Act (Pub. L. 92– 463, as amended), the National Science Foundation announces the following meeting: PO 00000 Frm 00063 Fmt 4703 Name: Advisory Committee for Environmental Research and education (9487). Dates: April 12, 2006, 8:30 a.m.–5 p.m. and April 13, 2006, 8:30 a.m.–3:30 p.m. Place: Stafford I, Room 1235, National Science Foundation, 4201 Wilson Blvd., Arlington, Virginia 22230. Type of Meeting: Open. Contact Person: Melissa Lane, Directorate for Geosciences, National Science Foundation, Suite 705, 4201 Wilson Blvd, Arlington, Virginia 22230. Phone 703–292–8500. Minutes: May be obtained from the contact person listed above. Purpose of Meeting: To provide advice, recommendations, and oversight concerning support for environmental research and education. Agenda April 12 Update on recent NSF environmental activities. Discussion of Observatory Workshop Report. Report by Director of OCI on Environmental Cyberinfrastructure. Report on NSF Strategic Plan Development. AC–ERE task group meetings. Presentation on the NAS International Human Dimensions of Global Change committee. April 13 AC–ERE task group reports. AC–ERE Advice on Development of Water Initiative. International Polar Year Update. Future of Dynamics of Coupled Natural and Human System Program. Discussion of Engineering themes on environment and sustainability. Meeting with the Director. Dated: March 21, 2006. Susanne Bolton, Committee Management Officer. [FR Doc. 06–2897 Filed 3–24–06; 8:45 am] BILLING CODE 7555–01–M NATIONAL SCIENCE FOUNDATION Proposal Review Panel for Materials Research; Notice of Meeting BILLING CODE 4410–09–P Manufacturer of Controlled Substances; Notice of Application Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on November 10, 2005, Organichem Corporation, 33 Riverside Avenue, Rensselaer, New York 12144, made application by renewal, and by letter on December 12, 2005, requesting the addition of Marihuana (7360) to their registration with the Drug Enforcement 15219 Sfmt 4703 In accordance with the Federal Advisory Committee Act (Pub. L. 92– 463 as amended), the National Science Foundation announces the following meeting: Name: Proposal Review Panel for Materials Research (DMR) #1203 Dates & Times: May 16, 2006; 7:30 a.m.–9 p.m.; May 17, 2006; 8 a.m.–4p.m. Place: University of Nebraska, Lincoln, NE. \\ALPHA3\E\FR\FM\27MRN1.SGM 27MRN1

Agencies

[Federal Register Volume 71, Number 58 (Monday, March 27, 2006)]
[Notices]
[Page 15219]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-4351]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on November 10, 2005, Organichem 
Corporation, 33 Riverside Avenue, Rensselaer, New York 12144, made 
application by renewal, and by letter on December 12, 2005, requesting 
the addition of Marihuana (7360) to their registration with the Drug 
Enforcement Administration (DEA) as a bulk manufacturer of the basic 
classes of controlled substances listed in Schedule I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Marihuana (7360)...........................  I
Tetrahydrocannabinols (7370)...............  I
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Pentobarbital (2270).......................  II
Hydrocodone (9193).........................  II
Meperidine(9230)...........................  II
Dextropropoxyphene (9273)..................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to manufacture bulk controlled substances for use 
in product development and for distribution to its customers. In 
reference to drug code 7360 (Marihuana), the company plans to bulk 
manufacture cannabindiol as a synthetic intermediate. This controlled 
substance will be further synthesized to bulk manufacture a synthetic 
THC (7370). No other activity for this drug code is authorized for this 
registration.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR Sec.  1301.33(a).
    Any such written comments or objections being sent via regular mail 
may be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC 20537, Attention: DEA Federal Register 
Representative, Liaison and Policy Section (ODL); or any being sent via 
express mail should be sent to DEA Headquarters, Attention: DEA Federal 
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria, 
Virginia 22301; and must be filed no later than May 1, 2006.

    Dated: March 20, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E6-4351 Filed 3-24-06; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.